CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-10 | Ruffo Frank Chief Financial Officer | Sale | −12,823 | $15.55 | $199K | 201,883 |
| 2022-03-02 | Ruffo Frank Chief Financial Officer | Option exercise | +8,297 | 214,706 | ||
| 2022-03-02 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −8,297 | 16,595 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise | +25,750 | 198,109 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise | +8,300 | 206,409 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +155,200 | 155,200 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +44,300 | 44,300 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −25,750 | 25,750 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −8,300 | 24,900 | ||
| 2022-02-09 | Ruffo Frank Chief Financial Officer | Sale | −1,388 | $12.66 | $18K | 172,359 |
| 2022-02-01 | Ruffo Frank Chief Financial Officer | Option exercise | +3,875 | 173,747 | ||
| 2022-02-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −3,875 | 0 | ||
| 2021-06-02 | Ruffo Frank Chief Financial Officer | Sale | −12,587 | $21.51 | $271K | 172,322 |
| 2021-06-02 | Ruffo Frank Chief Financial Officer | Sale | −2,450 | $22.30 | $55K | 169,872 |
| 2021-06-01 | Ruffo Frank Chief Financial Officer | Option exercise | +33,189 | 184,909 | ||
| 2021-06-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −33,189 | 0 | ||
| 2021-04-26 | Ruffo Frank Chief Financial Officer | Sale | −27,239 | $25.79 | $703K | 151,820 |
| 2021-04-26 | Ruffo Frank Chief Financial Officer | Sale | −100 | $26.44 | $3K | 151,720 |
| 2021-04-23 | Ruffo Frank Chief Financial Officer | Sale | −29,200 | $26.64 | $778K | 179,859 |
| 2021-04-23 | Ruffo Frank Chief Financial Officer | Sale | −800 | $27.33 | $22K | 179,059 |
Page 1 of 5 · 88 trades